-
1
-
-
0037530223
-
Cytomegalovirus retinitis in 2003
-
Dunn JP. Cytomegalovirus retinitis in 2003. Hopkins HIV Rep. 2003;15:8-11.
-
(2003)
Hopkins HIV Rep
, vol.15
, pp. 8-11
-
-
Dunn, J.P.1
-
2
-
-
33747795612
-
Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)
-
Steininger C, Puchhammer-Stöckl E, Popow-Kraupp T. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol. 2006;37:1-9.
-
(2006)
J Clin Virol
, vol.37
, pp. 1-9
-
-
Steininger, C.1
Puchhammer-Stöckl, E.2
Popow-Kraupp, T.3
-
3
-
-
0041941609
-
Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360)
-
Erice A, Tierney C, Hirsch M, et al. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis. 2003;37:567-578.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 567-578
-
-
Erice, A.1
Tierney, C.2
Hirsch, M.3
-
4
-
-
33745279068
-
Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation
-
Lengerke C, Ljubicic T, Meisner C, et al. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;38:53-60.
-
(2006)
Bone Marrow Transplant
, vol.38
, pp. 53-60
-
-
Lengerke, C.1
Ljubicic, T.2
Meisner, C.3
-
5
-
-
0034460083
-
Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3 0 for quantification of human immunodeficiency virus type 1 RNA in plasma
-
Murphy DG, Côté L, Fauvel M, et al. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2000;38:4034-4041.
-
(2000)
J Clin Microbiol
, vol.38
, pp. 4034-4041
-
-
Murphy, D.G.1
Côté, L.2
Fauvel, M.3
-
6
-
-
33746824548
-
Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation
-
Hellinger WC, Bonatti H, Machicao VI, et al. Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation. Mayo Clin Proc. 2006;81:1029-1033.
-
(2006)
Mayo Clin Proc
, vol.81
, pp. 1029-1033
-
-
Hellinger, W.C.1
Bonatti, H.2
Machicao, V.I.3
-
7
-
-
3142646888
-
Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation
-
Lianghui G, Shusen Z, Tingbo L, et al. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation. Transplant Proc. 2004;36:1502-1505.
-
(2004)
Transplant Proc
, vol.36
, pp. 1502-1505
-
-
Lianghui, G.1
Shusen, Z.2
Tingbo, L.3
-
8
-
-
11144358263
-
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients
-
Humar A, Paya C, Pescovitz MD, et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients. Am J Transplant. 2004;4:644-649.
-
(2004)
Am J Transplant
, vol.4
, pp. 644-649
-
-
Humar, A.1
Paya, C.2
Pescovitz, M.D.3
-
9
-
-
1842534037
-
Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis
-
Howden BP, Michaelides A, Spelman DW, et al. Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis. Bone Marrow Transplant. 2003;32:795-800.
-
(2003)
Bone Marrow Transplant
, vol.32
, pp. 795-800
-
-
Howden, B.P.1
Michaelides, A.2
Spelman, D.W.3
-
10
-
-
0037614700
-
Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma
-
Leruez-Ville M, Ouachée M, Delarue R, et al. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol. 2003;41:2040-2046.
-
(2003)
J Clin Microbiol
, vol.41
, pp. 2040-2046
-
-
Leruez-Ville, M.1
Ouachée, M.2
Delarue, R.3
-
11
-
-
0000027197
-
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy
-
Salmon-Céron D, Mazeron MC, Chaput S, et al. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS. 2000;14:1041-1049.
-
(2000)
AIDS
, vol.14
, pp. 1041-1049
-
-
Salmon-Céron, D.1
Mazeron, M.C.2
Chaput, S.3
-
12
-
-
20244370518
-
Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies
-
Wohl DA, Zeng D, Stewart P, et al. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr. 2005;38:538-544.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 538-544
-
-
Wohl, D.A.1
Zeng, D.2
Stewart, P.3
-
13
-
-
0037105633
-
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease
-
Humar A, Kumar D, Boivin G, et al. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis. 2002;186:829-833.
-
(2002)
J Infect Dis
, vol.186
, pp. 829-833
-
-
Humar, A.1
Kumar, D.2
Boivin, G.3
-
14
-
-
11144358399
-
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients
-
Mattes FM, Hainsworth EG, Geretti AM, et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. J Infect Dis. 2004;189:1355-1361.
-
(2004)
J Infect Dis
, vol.189
, pp. 1355-1361
-
-
Mattes, F.M.1
Hainsworth, E.G.2
Geretti, A.M.3
-
15
-
-
0033556557
-
Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients
-
Humar A, Uknis M, Carlone-Jambor C, et al. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. Transplantation. 1999;67:94-97.
-
(1999)
Transplantation
, vol.67
, pp. 94-97
-
-
Humar, A.1
Uknis, M.2
Carlone-Jambor, C.3
|